title: Globetrotting firms: Canada's health biotechnology collaborations with developing countries.
abstract: A survey of Canadian biotech firms reveals that their biotech collaborations with developing countries are not only significant but also increasingly reciprocal in terms of the exchange of financial resources and technological know-how.
authors.affiliation: McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, Ontario, Canada.
authors.forename: Monali
authors.initials: M
authors.lastname: Ray
authors.forename: Abdallah S
authors.initials: AS
authors.lastname: Daar
authors.forename: Peter A
authors.initials: PA
authors.lastname: Singer
authors.forename: Halla
authors.initials: H
authors.lastname: Thorsteinsdóttir
mesh_terms: D001709:Biotechnology / Q000458:organization & administration*; D002170:Canada; D002681:China; D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D003906:Developing Countries; D004345:Drug Industry / Q000458:organization & administration; D006801:Humans; D007221:Industry / Q000458:organization & administration*; D007328:Insulin / Q000008:administration & dosage; D007391:International Cooperation; D012106:Research
chemical_list: D007328:Insulin